NanoVibronix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NanoVibronix and other ETFs, options, and stocks.About NAOV
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield.
CEODoron Robert Besser
CEODoron Robert Besser
Employees31
Employees31
HeadquartersTyler, Texas
HeadquartersTyler, Texas
Founded2003
Founded2003
Employees31
Employees31
NAOV Key Statistics
Market cap4.23M
Market cap4.23M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume12.06K
Average volume12.06K
High today$4.16
High today$4.16
Low today$3.87
Low today$3.87
Open price$4.09
Open price$4.09
Volume16.46K
Volume16.46K
52 Week high$162.50
52 Week high$162.50
52 Week low$3.87
52 Week low$3.87
Stock Snapshot
NanoVibronix(NAOV) stock is priced at $3.94, giving the company a market capitalization of 4.23M. It carries a P/E multiple of -0.04.
On 2025-11-19, NanoVibronix(NAOV) stock moved within a range of $3.87 to $4.16. With shares now at $3.94, the stock is trading +1.9% above its intraday low and -5.3% below the session's peak.
Trading volume for NanoVibronix(NAOV) stock has reached 16.46K, versus its average volume of 12.06K.
The stock's 52-week range extends from a low of $3.87 to a high of $162.50.
The stock's 52-week range extends from a low of $3.87 to a high of $162.50.
NAOV News
TipRanks 12h
NanoVibronix to rebrand, explore strategic alternatives for legacy technologiesNanoVibronix (NAOV) issued a letter to shareholders. The company said, “Since assuming the role of CEO in June 2025, our team has completed a comprehensive revi...
People also own
Based on the portfolios of people who own NAOV. This list is generated using Robinhood data, and it’s not a recommendation.